Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.
Pharma giant Pfizer has opted to retain Carat as its media agency after a review, the client has confirmed.
The company spent $1.3 billion on ads in 2009, and $600 million during the first six months of this year, according to Nielsen.
The review marks the second big pharma reassessment handed down in as many days. Yesterday, GlaxoSmithKline opted to switch shops after a review, awarding its $700 million U.S. assignment to Omicom’s PHD. WPP’s MediaCom was the incumbent.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in